May 1
|
InterCure Announces FY2024 Results and Provides Q1 2025 Update: Revenue of NIS 239 Million and Adjusted EBITDA of NIS 24 Million, Strong Start to 2025
|
Feb 12
|
InterCure Names Alexander Rabinovich as Chairman Replacing Ehud Barak
|
Apr 1
|
InterCure Announces Preliminary Estimated 2023 Revenue of NIS 351 million and EBITDA of over NIS 50 million
|